Jecho Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Jecho Biopharmaceuticals Co., Ltd., explained in plain language.
-
New injection shows promise in early bladder cancer trial
Disease control Not yet recruitingThis early-phase study tests a new drug called JL19001, given alone or with standard BCG therapy, in 18 adults with high-risk non-muscle invasive bladder cancer. The main goals are to check safety, find the best dose, and see how the body responds. Participants must have had comp…
Phase: PHASE1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New shot aims to restore immune defenses in HIV patients
Disease control Not yet recruitingThis early-stage study tests an injection called JL18008 in people with HIV whose immune systems haven't fully recovered despite standard treatment. The goal is to safely improve their CD4 cell counts, which help fight infections. About 52 adults will take part to see if the shot…
Phase: PHASE1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:04 UTC